Cabozantinib for Patients With Recurrent or Progressive Meningioma
Clinical trial NCT05425004 · RECRUITING
Trial details
- NCT number
- NCT05425004
- Sponsor
- Baptist Health South Florida
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2026-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.